These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39342285)

  • 1. Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia.
    Adeshara K; Di Marco E; Bordino M; Gordin D; Bernardi L; Cooper ME; Groop PH;
    Cardiovasc Diabetol; 2024 Sep; 23(1):350. PubMed ID: 39342285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between hyperglycemia, antioxidant capacity and some enzymatic and non-enzymatic antioxidants in African patients with type 2 diabetes.
    Pieme CA; Tatangmo JA; Simo G; Biapa Nya PC; Ama Moor VJ; Moukette Moukette B; Tankeu Nzufo F; Njinkio Nono BL; Sobngwi E
    BMC Res Notes; 2017 Mar; 10(1):141. PubMed ID: 28356165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration.
    Chiarelli F; Cipollone F; Romano F; Tumini S; Costantini F; di Ricco L; Pomilio M; Pierdomenico SD; Marini M; Cuccurullo F; Mezzetti A
    Diabetes; 2000 Jul; 49(7):1258-63. PubMed ID: 10909986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum angiopoietin-2: a promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes.
    Salem NA; Ismail WM; Hendawy SR; Abdelrahman AM; El-Refaey AM
    Eur J Pediatr; 2024 Sep; 183(9):3853-3862. PubMed ID: 38884820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between oxidant/antioxidant markers and proteinuria in type 2 diabetes: results in 142 patients.
    Rashidi A; Nakhjavani M; Esteghamati A; Asgarani F; Khalilzadeh O; Abbasi M; Safari R
    J Nephrol; 2009; 22(6):733-8. PubMed ID: 19967652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease.
    Hong N; Lee M; Park S; Lee YH; Jin SM; Kim JH; Lee BW
    Sci Rep; 2018 Apr; 8(1):6710. PubMed ID: 29712934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration.
    Apakkan Aksun S; Ozmen B; Ozmen D; Parildar Z; Senol B; Habif S; Mutaf I; Turgan N; Bayindir O
    J Diabetes Complications; 2003; 17(6):343-8. PubMed ID: 14583179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage and plasma antioxidant indices in Bangladeshi type 2 diabetic patients.
    Arif M; Islam MR; Waise TM; Hassan F; Mondal SI; Kabir Y
    Diabetes Metab; 2010 Feb; 36(1):51-7. PubMed ID: 20036596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus.
    Aouacheri O; Saka S; Krim M; Messaadia A; Maidi I
    Can J Diabetes; 2015 Feb; 39(1):44-9. PubMed ID: 25065473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and association of pro-oxidants with magnesium in patients with diabetic nephropathy.
    Kachhawa K; Kachhawa P; Agrawal D; Kumar S; Sarkar PD
    Saudi J Kidney Dis Transpl; 2019; 30(5):1032-1037. PubMed ID: 31696840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative Stress and Asprosin Levels in Type 2 Diabetic Patients with Good and Poor Glycemic Control.
    Senyigit A; Durmus S; Gelisgen R; Uzun H
    Biomolecules; 2024 Sep; 14(9):. PubMed ID: 39334889
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetic Kidney Disease: Is There a Role for Glycemic Variability?
    Subramanian S; Hirsch IB
    Curr Diab Rep; 2018 Feb; 18(3):13. PubMed ID: 29450720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
    Sözmen EY; Sözmen B; Delen Y; Onat T
    Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A; Forsblom C; Harjutsalo V; Groop PH; Gordin D;
    Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
    Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
    J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin microvascular endothelial dysfunction is associated with type 2 diabetes independently of microalbuminuria and arterial stiffness.
    Jonasson H; Bergstrand S; Nystrom FH; Länne T; Östgren CJ; Bjarnegård N; Fredriksson I; Larsson M; Strömberg T
    Diab Vasc Dis Res; 2017 Jul; 14(4):363-371. PubMed ID: 28482676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor Glycemic Control Is Associated With More Rapid Kidney Function Decline After the Onset of Diabetic Kidney Disease.
    Shah HS; McGill JB; Hirsch IB; Wu C; Galecki A; de Boer IH; Mauer M; Doria A
    J Clin Endocrinol Metab; 2024 Jul; 109(8):2124-2135. PubMed ID: 38262002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
    Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
    Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.